Fertility-preserving treatment in complex atypical hyperplasia and early endometrial cancer in young women with oral progestin: Is it effective?
Ji Sun Baek, Wan Ho Lee, Woo Dae Kang, Seok Mo Kim
Obstet Gynecol Sci. 2016;59(1):24-31.   Published online 2016 Jan 15     DOI: https://doi.org/10.5468/ogs.2016.59.1.24
Citations to this article as recorded by Crossref logo
Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia
Yiqin Wang, Rong Zhou, Haibo Wang, Huixin Liu, Jianliu Wang
International Journal of Gynecologic Cancer.2019; 29(4): 699.     CrossRef
Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience
Yao Wang, Mei Yu, Jia-xin Yang, Dong-yan Cao, Zhen Yuan, Hui-mei Zhou, Ying Zhang, Lei Li, Keng Shen, Huanwen Wu
International Journal of Clinical Oncology.2019; 24(6): 712.     CrossRef
Molecular expression characteristics confirm the malignancy concealed by morphological alterations in endometrial cancer after fertility-preserving treatment
Ting Wen Yi Hu, Lei Li, E. Yang, Dan Nie, Zheng Yu Li
Archives of Gynecology and Obstetrics.2019; 299(6): 1673.     CrossRef
A systematic review and meta‐analysis of prognostic factors for remission in fertility‐sparing management of endometrial atypical hyperplasia and adenocarcinoma
Sarah Guillon, Nathalie Popescu, Juliette Phelippeau, Martin Koskas
International Journal of Gynecology & Obstetrics.2019; 146(3): 277.     CrossRef
Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a
A-ying Ma, Shu-wu Xie, Jie-yun Zhou, Yan Zhu
International Journal of Molecular Sciences.2017; 18(7): 1337.     CrossRef
Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia
Qing Zhang, Gonghua Qi, Margaux J. Kanis, Ruifen Dong, Baoxia Cui, Xingsheng Yang, Beihua Kong
Oncotarget.2017; 8(34): 57642.     CrossRef